Financials

  • Market Capitalization 436.18 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.53
Relación precio/flujo de caja
8.08

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3007
SGMT
Sagimet Biosciences Inc. - Series A Common Stock
7.15 USD-2.99%-7.74%+8.99%-23.94%441.53 M USD
3012
SLN
Silence Therapeutics Plc - American Depository Share
9.29 USD+2.20%-12.44%+36.82%+46.99%438.81 M USD
3022
CCCC
C4 Therapeutics, Inc. - Common Stock
3.92 USD-3.45%-5.54%-1.51%+64.71%433.42 M USD
3037
ASMB
Assembly Biosciences, Inc. - Common Stock
26.96 USD-1.61%-7.03%+13.90%-8.38%428.46 M USD